Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas:: a study of 60 tumors

被引:22
作者
Cerdá-Nicolás, M
López-Gines, C
Pérez-Bacete, M
Barcia-Salorio, JL
Llombart-Bosch, A
机构
[1] Univ Valencia, Dept Pathol, Sch Med, Valencia 46010, Spain
[2] Univ Clin Hosp Valencia, Dept Surg, Valencia, Spain
关键词
histopathology; karyotype; meningiomas;
D O I
10.1023/A:1006454107467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Meningiomas may display benign (Grade I), atypical (Grade II) and anaplastic (Grade III) histopathological findings. The cytogenetic studies strongly suggest that secondary changes (moreover loss of chromosome 22) appear to be associated with more atypical features and with greater clinical aggressivity. We studied 60 tumors from 52 patients. Histopathological features such as nuclear pleomorphism, nucleolar prominence, mitosis, necrosis, cellular density, PCNA labeling index, and karyotype have been evaluated. Nuclear pleomorphism and nucleolar prominence showed a progressive increase in Grades I-III. Multifocal micronecrosis was considered a criterion of malignancy. A significant correlation was observed between PCNA-LI, mitotic index and grades. Complex karyotypes increased progressively: benign (34% of cases), atypical (45% of cases) and anaplastic (70% of cases). The most common numerical alterations were losses of chromosomes 10, 14, 18 and 22. The chromosomes most often involved in structural anomalies were: 1, 4, 7, 14 and 22. Telomeric associations was present in four cases and double minutes in two cases. Prognostic criteria for these tumors have been analyzed on the basis of these data.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 42 条
[1]   CYTOGENETIC STUDIES OF HUMAN-BRAIN TUMORS AND THEIR CLINICAL-SIGNIFICANCE .2. MENINGIOMA [J].
ALSAADI, A ;
LATIMER, F ;
MADERCIC, M ;
ROBBINS, T .
CANCER GENETICS AND CYTOGENETICS, 1987, 26 (01) :127-141
[2]  
BELLO MJ, 1993, CANCER GENET CYTOGEN, V66, P117
[3]  
BIGNER SH, 1988, CANCER RES, V48, P3939
[4]   MENINGIOMAS [J].
BLACK, PM .
NEUROSURGERY, 1993, 32 (04) :643-657
[5]  
BRODEUR GM, 1981, CANCER RES, V41, P4678
[6]   KARYOTYPIC EVOLUTION OF HUMAN MENINGIOMA - PROGRESSION THROUGH MALIGNANCY [J].
CASARTELLI, C ;
ROGATTO, SR ;
NETO, JB .
CANCER GENETICS AND CYTOGENETICS, 1989, 40 (01) :33-45
[7]  
Cerda-Nicolas N, 1998, CLIN NEUROPATHOL, V17, P210
[8]  
CHEN WYK, 1990, CLIN NEUROPATHOL, V9, P74
[9]   PREDICTION OF RECURRENCE IN MENINGIOMAS AFTER SURGICAL-TREATMENT - A QUANTITATIVE APPROACH [J].
CHRISTENSEN, D ;
LAURSEN, H ;
KLINKEN, L .
ACTA NEUROPATHOLOGICA, 1983, 61 (02) :130-134
[10]   Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma [J].
Cobb, MA ;
Husain, M ;
Andersen, BJ ;
AlMefty, O .
JOURNAL OF NEUROSURGERY, 1996, 84 (01) :85-90